0001470930-16-000002.txt : 20160921 0001470930-16-000002.hdr.sgml : 20160921 20160921131232 ACCESSION NUMBER: 0001470930-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160921 DATE AS OF CHANGE: 20160921 EFFECTIVENESS DATE: 20160921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOXINESS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001470930 IRS NUMBER: 262157552 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271024 FILM NUMBER: 161895354 BUSINESS ADDRESS: STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106 CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 510 724 1548 MAIL ADDRESS: STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106 CITY: HERCULES STATE: CA ZIP: 94547 D 1 primary_doc.xml X0707 D LIVE 0001470930 BIOXINESS PHARMACEUTICALS, INC. 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA CALIFORNIA 94547 510 724 1548 CALIFORNIA Bioxiness Health Specialties International None Corporation true Mansour Bassiri c/o Bioxiness Pharmaceuticals, Inc. 750 Alfred Nobel Dr. Suite 106 Hercules CA CALIFORNIA 94547 Executive Officer Director Promoter Susan Froshauer c/o Bioxiness Pharmaceuticals, Inc. 750 Alfred Nobel Dr. Suite 106 Hercules CA CALIFORNIA 94547 Director Matthew Kerby c/o Bioxiness Pharmaceuticals, Inc. 750 Alfred Nobel Dr. Suite 106 Hercules CA CALIFORNIA 94547 Director Constance McKee c/o Bioxiness Pharmaceuticals, Inc. 750 Alfred Nobel Dr. Suite 106 Hercules CA CALIFORNIA 94547 Director Clinton Severson c/o Bioxiness Pharmaceuticals, Inc. 750 Alfred Nobel Dr. Suite 106 Hercules CA CALIFORNIA 94547 Director Pharmaceuticals Decline to Disclose 06b false 2016-09-06 false true true Conversion of convertible notes into equity false 0 1000000 502000 498000 true 18 29 0 0 2000 true false BIOXINESS PHARMACEUTICALS, INC. /s/Mansour Bassiri Mansour Bassiri Chief Executive Officer 2016-09-21